A generikus rosuvastatin hatékonyságának vizsgálata cerebrovascularis betegekben

Translated title of the contribution: Effectiveness of generic rosuvastatin in patients with ischaemic cerebrovascular disease

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Statin therapy is the cornerstone of anti-atherosclerotic treatment, and it considered obligatory in the secondary prevention of atherosclerotic diseases. Rosuvastatin is well-known and efficacious lipid-lowering agent. Generic drugs are more frequently used instead of its ancestors. Generic rosuvastatin forms have been aproved recently to the Central European market, but their safety and efficacy have not been previously examined in cerebrovascular patient populations. Patients and methods: 109 patients with documented ischaemic cerebrovascular events were included in our study. 20 mg generic rosuvastatin significantly decreased total cholesterol (5.47 vs. 3.88 mmol/l, p

Original languageHungarian
Pages (from-to)857-860
Number of pages4
JournalOrvosi Hetilap
Volume153
Issue number22
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Cerebrovascular Disorders
Generic Drugs
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Secondary Prevention
Cholesterol
Lipids
Safety
Therapeutics
Population
Rosuvastatin Calcium

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A generikus rosuvastatin hatékonyságának vizsgálata cerebrovascularis betegekben. / Szapáry, L.; Fehér, G.

In: Orvosi Hetilap, Vol. 153, No. 22, 06.2012, p. 857-860.

Research output: Contribution to journalArticle

@article{cb3bf7d2c531491598fcff12cb77e1c7,
title = "A generikus rosuvastatin hat{\'e}konys{\'a}g{\'a}nak vizsg{\'a}lata cerebrovascularis betegekben",
abstract = "Statin therapy is the cornerstone of anti-atherosclerotic treatment, and it considered obligatory in the secondary prevention of atherosclerotic diseases. Rosuvastatin is well-known and efficacious lipid-lowering agent. Generic drugs are more frequently used instead of its ancestors. Generic rosuvastatin forms have been aproved recently to the Central European market, but their safety and efficacy have not been previously examined in cerebrovascular patient populations. Patients and methods: 109 patients with documented ischaemic cerebrovascular events were included in our study. 20 mg generic rosuvastatin significantly decreased total cholesterol (5.47 vs. 3.88 mmol/l, p",
keywords = "generic, prevention, statin, stroke, transient ischaemic attack",
author = "L. Szap{\'a}ry and G. Feh{\'e}r",
year = "2012",
month = "6",
doi = "10.1556/OH.2012.29390",
language = "Hungarian",
volume = "153",
pages = "857--860",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "22",

}

TY - JOUR

T1 - A generikus rosuvastatin hatékonyságának vizsgálata cerebrovascularis betegekben

AU - Szapáry, L.

AU - Fehér, G.

PY - 2012/6

Y1 - 2012/6

N2 - Statin therapy is the cornerstone of anti-atherosclerotic treatment, and it considered obligatory in the secondary prevention of atherosclerotic diseases. Rosuvastatin is well-known and efficacious lipid-lowering agent. Generic drugs are more frequently used instead of its ancestors. Generic rosuvastatin forms have been aproved recently to the Central European market, but their safety and efficacy have not been previously examined in cerebrovascular patient populations. Patients and methods: 109 patients with documented ischaemic cerebrovascular events were included in our study. 20 mg generic rosuvastatin significantly decreased total cholesterol (5.47 vs. 3.88 mmol/l, p

AB - Statin therapy is the cornerstone of anti-atherosclerotic treatment, and it considered obligatory in the secondary prevention of atherosclerotic diseases. Rosuvastatin is well-known and efficacious lipid-lowering agent. Generic drugs are more frequently used instead of its ancestors. Generic rosuvastatin forms have been aproved recently to the Central European market, but their safety and efficacy have not been previously examined in cerebrovascular patient populations. Patients and methods: 109 patients with documented ischaemic cerebrovascular events were included in our study. 20 mg generic rosuvastatin significantly decreased total cholesterol (5.47 vs. 3.88 mmol/l, p

KW - generic

KW - prevention

KW - statin

KW - stroke

KW - transient ischaemic attack

UR - http://www.scopus.com/inward/record.url?scp=84861751804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861751804&partnerID=8YFLogxK

U2 - 10.1556/OH.2012.29390

DO - 10.1556/OH.2012.29390

M3 - Article

VL - 153

SP - 857

EP - 860

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 22

ER -